Cargando…
Correction: Reducing the number of systematic biopsy cores in the era of MRI targeted biopsy—implications on clinically-significant prostate cancer detection and relevance to focal therapy planning
Autores principales: | Lee, Alvin Y. M., Chen, Kenneth, Tan, Yu Guang, Lee, Han Jie, Shutchaidat, Vipatsorn, Fook-Chong, Stephanie, Cheng, Christopher W. S., Ho, Henry S. S., Yuen, John S. P., Ngo, Nye Thane, Law, Yan Mee, Tay, Kae Jack |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705233/ https://www.ncbi.nlm.nih.gov/pubmed/35228666 http://dx.doi.org/10.1038/s41391-022-00513-w |
Ejemplares similares
-
Reducing the number of systematic biopsy cores in the era of MRI targeted biopsy—implications on clinically-significant prostate cancer detection and relevance to focal therapy planning
por: Lee, Alvin Y. M., et al.
Publicado: (2022) -
Surveillance one year post focal cryotherapy for clinically significant prostate cancer using mpMRI and PIRADS v2.1: An initial experience from a prospective phase II mandatory biopsy study
por: Velaga, Jyothirmayi, et al.
Publicado: (2023) -
Defining prostate cancer size and treatment margin for focal therapy: does intralesional heterogeneity impact the performance of multiparametric MRI?
por: Aslim, Edwin Jonathan, et al.
Publicado: (2021) -
Outcomes of combination MRI-targeted and transperineal template biopsy in restaging low-risk prostate cancer for active surveillance
por: Chen, Kenneth, et al.
Publicado: (2018) -
What is the ideal number of biopsy cores per lesion in targeted prostate biopsy?
por: Sonmez, Gokhan, et al.
Publicado: (2020)